OMCL
Omnicell Inc
NASDAQ: OMCL · HEALTHCARE · HEALTH INFORMATION SERVICES
$32.79
+1.67% today
Updated 2026-09-11
Market cap
$1.56B
P/E ratio
40.92
P/S ratio
1.25x
EPS (TTM)
$0.84
Dividend yield
—
52W range
$29 – $55
Volume
0.7M
Omnicell Inc (OMCL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$32.79
12-Month target
$0.27
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.1B | $1.1B | $1.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 3.14%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.